Literature DB >> 7683167

Striosomal arrangement of met-enkephalin and substance P expression in parkinsonism-dementia complex on Guam.

H Ito1, S Goto, S Sakamoto, A Hirano.   

Abstract

This report concerns a topographic immunohistochemical analysis of Met-enkephalin (MEnk) and substance P (SP) expression in the striatum from seven patients with parkinsonism-dementia complex on Guam (PDC). The striatum of seven neurologically normal subjects served as controls. MEnk-positive striosomes were readily visualized in both the caudate nucleus and the putamen of the PDC cases. Although the immunoreactivity was less than that of MEnk, SP-positive patches were detected in the PDC striatum. The patches were similar to those seen in the normal controls. These results provide additional evidence that the striatum and its efferent system appear to be preserved in patients with PDC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683167     DOI: 10.1007/bf00334449

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Striosomal organization of substance P-like immunoreactivity in parkinsonian patients.

Authors:  S Sakamoto; S Goto; H Ito; A Hirano
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

2.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features.

Authors:  A HIRANO; L T KURLAND; R S KROOTH; S LESSELL
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

3.  A comparative immunohistochemical study on striatal Met-enkephalin expression in Alzheimer's disease and in progressive supranuclear palsy.

Authors:  S Matsumoto; S Goto; A Hirano
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 4.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

Review 5.  Fiber connections of the basal ganglia.

Authors:  A M Graybiel; C W Ragsdale
Journal:  Prog Brain Res       Date:  1979       Impact factor: 2.453

6.  An immunohistochemical study of enkephalins and other neuropeptides in the striatum of the cat with evidence that the opiate peptides are arranged to form mosaic patterns in register with the striosomal compartments visible by acetylcholinesterase staining.

Authors:  A M Graybiel; C W Ragsdale; E S Yoneoka; R P Elde
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

7.  The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems.

Authors:  C R Gerfen
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.

Authors:  S Goto; A Hirano; S Matsumoto
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

9.  Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.

Authors:  C M Waters; R Peck; M Rossor; G P Reynolds; S P Hunt
Journal:  Neuroscience       Date:  1988-05       Impact factor: 3.590

Review 10.  The nigrostriatal system in Parkinson's disease.

Authors:  A M Graybiel; E C Hirsch; Y Agid
Journal:  Adv Neurol       Date:  1990
View more
  3 in total

1.  Topographic involvement of the striatal efferents in basal ganglia of patients with adult-onset motor neuron disease with basophilic inclusions.

Authors:  H Ito; H Kusaka; S Matsumoto; T Imai
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

Review 3.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.